International registration is the process of obtaining regulatory authorization to legally sell a medical device in a target country or region. It combines device classification, quality management system evidence, technical documentation, and jurisdiction-specific submissions, such as an FDA 510(k), CE marking under EU MDR, or a national import license.
What is international registration?
International registration refers to securing market authorization for a medical device across one or more countries, each governed by its own rules. It is not a single filing. Every market defines its own device classes, evidence expectations, and submission formats.
The work sits at the transition from development to commercialization and continues through the product lifecycle. It splits into two connected parts: premarket authorization, meaning clearance or approval of the device itself (for example, an FDA 510(k) or a CE certificate), and entity registration, meaning the listing of the manufacturer, its devices, and local operators in national databases.
Why international registration matters in medical device development
Registration is the legal gate to a market. Selling or importing a device without the required authorization is unlawful and exposes a company to import refusals, seizures, recalls, and financial penalties. For most medtech businesses, approval timelines directly shape revenue, since a delayed clearance pushes back every downstream sale.
Getting classification or evidence wrong early forces expensive rework later. A device treated as low-risk may face a full clinical review once a reviewer disagrees, resetting the schedule. Registration also ties into post-market duties: vigilance reporting, surveillance, and database upkeep all reference the original submission, so mistakes there follow the product for years.
How international registration works
International registration follows a similar backbone in most jurisdictions, even when the paperwork differs. A typical path runs through these steps:
- Classify the device: risk class drives everything that follows. The US uses Class I, II, and III; EU MDR 2017/745 uses I, IIa, IIb, and III; IVDR 2017/746 uses A to D. The same device can land in different classes across markets.
- Build and certify the quality system: ISO 13485:2016 is the shared baseline. Since February 2, 2026, the FDA QMSR incorporates ISO 13485:2016 by reference into 21 CFR Part 820.
- Assemble technical documentation: this covers the technical file or design dossier, design history file, risk management to ISO 14971, and a clinical evaluation report.
- Complete the premarket pathway: in the US, that means a 510(k), De Novo, or PMA. In the EU, a Notified Body runs conformity assessment under EU MDR or IVDR, leading to CE marking.
- Appoint local representation: the EU requires an Authorized Representative; other countries require a resident license holder or agent.
- Register entities and devices: US firms complete FDA establishment registration and device listing under 21 CFR Part 807. EU operators register in EUDAMED, whose core modules became mandatory on 28 May 2026 under Commission Decision (EU) 2025/2371.
- Maintain and renew: certificates expire, standards update, and surveillance data must be filed on schedule.
Programs like the Medical Device Single Audit Program (MDSAP) let one ISO 13485 audit satisfy five regulators at once: the US FDA, Health Canada, Australia’s TGA, Brazil’s ANVISA, and Japan’s MHLW and PMDA. That consolidation cuts duplicate audits for manufacturers selling across those markets.
Common challenges and best practices
The most common mistake is assuming one market’s outcome carries to another. A device cleared through a US 510(k) may need a Notified Body review and stronger clinical evidence in the EU, where MDR raised the bar for many product types. Teams also underestimate documentation upkeep, letting technical files drift out of sync across markets as design changes accumulate.
Good practice starts with one master technical file, structured so each jurisdiction’s submission draws from a single source of truth. Map every requirement to its market early, sequence submissions around business priorities instead of filing everywhere at once, and plan EUDAMED and UDI data entry well before launch. Where several target markets participate in MDSAP, a single audit can remove redundant quality inspections and free regulatory bandwidth.
How SJML helps with international registration
SJML runs international registration as part of its Compliance-as-a-Service offering. The QARA team supports device classification and regulatory strategy, then prepares submissions across major frameworks: FDA 510(k), CE marking under EU MDR and IVDR, and country-specific approvals, including technical files and design history documentation. The team builds and sustains quality systems to ISO 13485 and MDSAP, manages EUDAMED registration, and supports India market access through CDSCO manufacturing, test, and import pathways. Because design, manufacturing, and compliance sit under one roof, registration evidence stays aligned with the actual product and its production record.
Frequently asked questions
No. CE marking is the specific route to selling a device in the European Union, granted after conformity assessment under EU MDR or IVDR. International registration is the wider effort of gaining authorization across several markets, with CE marking as one component alongside pathways like the FDA 510(k) or a national import license used in other countries.
Usually yes. Each regulator maintains its own classification rules, evidence requirements, and submission process, so a manufacturer files separately in most markets. Some mechanisms reduce the load: MDSAP lets one quality audit serve five countries, and certain regulators accept reliance on approvals from reference markets, though the device registration itself still happens locally.
Timelines depend on device class and pathway. A straightforward FDA 510(k) can clear in a few months, while a US PMA or a high-risk EU MDR conformity assessment often runs well over a year. Quality system certification, clinical evidence gaps, and Notified Body capacity are the usual factors that stretch schedules, so teams plan submissions early.
EUDAMED is the European Database on Medical Devices, used to register economic operators, devices, certificates, and market surveillance data. Under Commission Decision (EU) 2025/2371, its first four modules became mandatory on 28 May 2026. Manufacturers placing devices on the EU market must register their organization and products before those devices reach the market.
Related terms
- CE Marking
- FDA 510(k) Clearance
- EU MDR 2017/745
- Authorised Representative
- MDSAP
